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Introduction: Routine coagulation tests have a low predictability for perioperative bleeding complications, and
spinal hematoma after removal of epidural catheters is very infrequent. Thromboelastometry and point-of-care
platelet aggregometry may improve hemostatic monitoring but have not been studied in the context of safety
around epidural removal.
Methods: Twenty patients who received an epidural catheter for major thoracoabdominal and abdominal surgery
were included prospectively. In addition to routine coagulation tests, rotational thromboelastometry and multiple
electrode platelet aggregometry were carried out.
Results: A coagulation deficit was suggested by routine coagulation tests on the intended day of epidural catheter
removal in four out of 20 patients. Prothrombin time-international normalized ratio was elevated to 1.5 in one
patient (normal range: 0.9 to 1.2) while rotational thromboelastometry and multiple electrode platelet aggregometry
parameters were within normal limits. Activated partial thromboplastin time was elevated to 47 to 50 seconds in
the remaining three patients (normal range 28 to 45 seconds). Rotational thromboelastometry showed that one of
the patients’ results was due to heparin effect: the clotting time with the HEPTEM® activator was 154 seconds as
compared to 261 seconds with INTEM. The three remaining patients with prolonged routine coagulation test results
had all received over 1L of hydroxyethyl starch (Venofundin®) and thrombosis prophylaxis with low-molecular-
weight heparin (enoxaparin). Rotational thromboelastometry and multiple electrode platelet aggregometrygave
normal or hypercoagulative signals in most patients.
Conclusions: This case series is new in that it examines rotational thromboelastometry and multiple electrode
platelet aggregometry postoperatively in the context of epidural analgesia and shows that they may be clinically
useful. These methods should be validated before they can be used for standard patient care.
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Analgesia and anesthesia by administration of a local
anesthetic and an opiate through an epidural catheter
provide effective pain control during and after major
surgery, and are routinely used at our hospital. Hema-
toma within the spinal canal is a serious complication of
epidural analgesia causing neurological damage and
requiring urgent surgical decompression. They are most
likely at the time of epidural catheterization, when the
risk is estimated to be between 1:4000 and 1:30,000, and
at the time of removal or manipulation of epidural cath-
eters when the risk is estimated to be between 1:150,000
and 1:190,000 [1,2]. Patients who have undergone major
surgery often have a coagulation deficit which may be
caused by loss of coagulation factors and platelets due to
surgical hemorrhage, preoperative malnutrition, systemic
inflammation response syndrome, or due to accumula-
tion or overdosing of thrombosis prophylaxis.
It is uncontroversial that preoperative coagulation def-
icits predispose to spinal hematoma at the time of epi-
dural catheterization, but the sensitivity and specificity
of routine coagulation tests, usually the prothrombin
time-international normalized ratio (PT-INR), activated
partial thromboplastin time (aPTT) and platelet count
(Plc), in this context are unknown. These tests’ useful-
ness is questionable in patients who lack risk factors for
perioperative bleeding, such as a history of bleeding or
taking anticoagulant drugs [3-5]. It is more uncertain
whether these tests can indicate the risk of hemorrhagic
complications related to postoperative manipulation and
removal of epidural catheters. A number of case reports
suggest that point-of-care tests measuring whole blood
viscoelasticity (e.g. thromboelastography (TEG®) and
rotational thromboelastometry (ROTEM®)) and platelet
aggregometry (e.g. multiple electrode platelet aggrego-
metry (Multiplate®) and VerifyNow®) may be of use in
regional anesthesia but evidence here is scarce.
Ahead of a larger study which is currently in progress,
we carried out a pilot study, approved by The Swedish
Central Ethical Review Board (Lund, DNR 2010/482).
Signed consent was given by 20 consecutive patients
who had an epidural catheter in place for analgesia after
major gastrointestinal surgery. Our aim was to compare
results from point-of-care and routine coagulation tests,
hypothesizing that the whole blood assays ROTEM® and
Multiplate® might give normal results despite moderately
abnormal routine test results, which are run on plasma.
This would of course be of interest since it is a common
clinical scenario to be presented with a patient whose
epidural catheter needs to be removed but whose
routine coagulation parameters suggest a mild bleeding
diathesis. We also compared preoperative routine coagu-
lation results with postoperative results to confirm our
clinical impression that the normal pattern of coagulationin these patients is a tendency towards coagulopathy as
measured by PT-INR and aPTT.
Results
Included in the study were 20 patients with a thoracic
epidural catheter in place, 13 men and seven women. Of
the 20 patients, 15 had undergone major gastrointestinal
surgery by laparotomy alone and the other five had also
undergone thoracotomy. The mean age was 58 years
(range 26 to 83). None were treated with platelet inhibi-
tors. Mean blood loss during their operation was 415mL
(standard deviation 315mL). All patients received 500mL
or more of synthetic colloid as hydroxyethyl starch
130/0.42 (Venofundin®). All were treated with throm-
bosis prophylaxis in a standard once daily dose at 8 p.m.
of 40mg enoxaparin irrespective of weight. The mean time
between epidural catheterization and removal was 5.6 days
(range 2 to 14 days, standard deviation 2.8 days). A small
number of routine test results were missing (four pre-
operative PT-INR values, one preoperative Plc and one
postoperative aPTT).
Routine test results in the 20 patients
Postoperative aPTT and PT-INR results were as
expected significantly prolonged at the time of removal
of epidural catheters in comparison to those taken pre-
operatively (aPTT: mean 39.5 seconds, SD 0.15 versus
32.2 seconds, SD 4.84; PT-INR: mean 1.08, SD 0.15 ver-
sus 1.01, SD 0.11; see Figures 1 and 2). There was also,
unsurprisingly, a significant correlation (p<0.05; r=0.76)
between the length of time after operation and Plc
(see Figure 1). Normal values are shown in Table 1.
Multiplate® test results in the 20 patients
Median Multiplate® area under curve (AUC) was for all
three tests within the reference ranges (see Table 2): after
activation by adenosine diphosphate (ADP) it was 98U;
after activation by collagen (COL) it was 104U and after
activation with thrombin receptor activator (TRAP) it
was 128U. AUC after activation with ADP correlated
significantly to the length of time between operation and
testing (see Figure 2) but AUC after activation with COL
or TRAP did not (not shown).
ROTEM® test results in the 20 patients
Out of a total of 480 results, 18 (4%) from the 20
patients (24 parameters per patient) were not included:
results were excluded in four patients due to desiccation
artifacts, caused by the surface of the sample drying and
clotting, or an inconsistent pattern of results suggesting
that the wrong reagents had been used. Median results
for each test’s results were within the normal ranges
(see Table 2). Median maximum clot firmness (MCF)
for each of the assays was as follows: EXTEM: 71mm;








































































































Figure 1 Results from assays related mainly to platelet count and function. These results give an overall impression of normo- or
hypercoagulability. Shaded areas indicate the normal ranges. Platelet count, ROTEM®-FIBTEM®-maximum clot firmness (taken to be a quantitative
measure of blood fibrinogen concentration) and Multiplate® adenosine diphosphate-area under curve (a measure of platelet activity) all correlated
significantly to the length of time after surgery (p<0.05, r=0.89, 0.76 and 0.49 respectively). ROTEM®-EXTEM-maximum clot firmness, an overall
measure of the extrinsic pathway, neither increased nor decreased with time after operation while ROTEM®-(EXTEM minus FIBTEM®)-maximum clot
firmness significantly negatively correlated to time after operation (p<0.05, r=−0.89). The latter measure is often taken to be a measure of platelet
function but here its decrease would appear to be due to increasing fibrinogenemia rather than weaning platelet function. *: significant
correlation p<0.05. ADP: adenosine diphosphate. AUC: area under curve. MCF: maximum clot firmness. N/S: no significant correlation.
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APTEM: 70mm; NATEM: 66mm. There were no sig-
nificant differences between EXTEM and APTEM
results, which would have indicated hyperfibrinolysis.
Of the results, 61 (13%) indicated mild hypercoagula-
bility and 16 of these were NATEM-clot formation
time (CFT) measurements. Five results (1%) indicated
hypocoagulability, but four of these were HEPTEM®
results in patients whose INTEM results were normal,
which ought to be impossible since HEPTEM® is
identical to INTEM other than it contains heparinase,
which would not be expected to inhibit coagulation.There was no significant difference between results
from INTEM and HEPTEM®, which would have suggested
an excessive heparin effect.
Case studies of the four patients with abnormal routine
coagulation results
Case report 1: normal ROTEM® and Multiplate® despite a
prothrombin time-international normalized ratio of 1.5
A previously healthy 26-year-old woman weighing
67kg and not on any medication other than
aluminum oxide and antacids due to dyspepsia, pre-
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Figure 2 Perioperative dynamics of activated partial thromboplastin time and prothrombin time-international normalized ratio. These
results give an overall impression of postoperative normo- or hypocoagulability. Shaded areas indicate the manufacturers’ reference ranges.
aPTT: activated partial thromboplastin time. PT-INR: prothrombin time-international normalized ratio. Preop: preoperative test results. Postop: test
results taken on the day on which epidural catheters were removed. s: seconds. *: significant difference between pre- and postoperative results
(p<0.05, Student’s paired t-test).
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net resonance imaging suggested pancreatic malig-
nancy, Whipple’s procedure was carried out, involving
extensive pancreas resection. The operation was con-
ducted under uncomplicated combined inhalational
general and epidural anesthetic: the total perioperative
hemorrhage was 700mL and in addition to crystalloid
infusions (Ringer’s acetate and glucose solution), this pa-
tient received 2000mL of hydroxyethyl starch (Venofundin®
60mg/mL) and 250mL of 5% human albumin. Routine
coagulation tests on the first postoperative day indicated a
coagulopathy (see Table 3). Thrombosis prophylaxis was
omitted that evening but continued thereafter. On the
morning of the fourth postoperative day, ROTEM® andMultiplate® results were within their reference ranges des-
pite a PT-INR of 1.5 (see Table 3). The patient’s epidural
catheter was removed without complication 14 hours after
the last dose of enoxaparin.
Case report 2: contamination by heparin demonstrated by
ROTEM®
A 61-year-old man weighing 52kg but who had recently
lost 50kg was admitted for resection of a lower esopha-
geal tumor. He had previously received a subcutaneous
venous port (Port-a-Cath™) for adjuvant chemotherapy
and a percutaneous gastromy for nutrition. He had been
prescribed oral esomeprazole, ondansetron, betame-
thasone, diazepam and mirtazapine in addition to
Table 1 Summary of assays performed
Test Vial Apparatus Place of analysis Normal range
ROTEM® using the following reagents:
EXTEM, FIBTEM®, INTEM, APTEM, NATEM,
HEPTEM®, recording the following results:
CT (Clotting time), CFT (Clot formation time),
Alpha-Angle (AA), MCF (Maximum Clot Firmness),
ML (Maximum Lysis).
2.7mL citrate tubes for ROTEM® analysis







Multiplate® using the following agonists:
adenosine diphosphate, collagen, thrombin
receptor activator, recording the following results
for each agonist: area under curve (AUC),
aggregation (AU), velocity (AU/min).





aPTT: activated partial thromboplastin time 2.7mL citrate tubes (3.2% citrate,
BD Vacutainer® Systems, Plymouth, UK)
PTT-Automate, Stago
(Asnière sur Seine, France)
Hospital’s usual clinical
chemistry laboratory




Stago prothrombin complex assay,
Stago calibrated by Equalis,
(Uppsala, Sweden)
≤1.2
Plc: platelet count 3.0mL K2EDTA tubes (BD Vacutainer® Systems,
Plymouth UK)
Sysmex XE 5000 cell counter,
Sysmex Corp., (Kobe, Japan).
165 to 387 million/mL and 145 to




















Table 2 Reference ranges for ROTEM® (Manufacturer’s information) and Multiplate® [6]
ROTEM® CT (s) CFT (s) Alpha angle (°) MCF (mm)
EXTEM 38–79 34–159 63–83 50–72
APTEM 38–79 34–149 63–83 50–72
INTEM 100–240 30–110 70–83 50–72
HEPTEM® 100–240 30–110 70–83 50–72
NATEM 300–1000 150–700 30–70 40–65
FIBTEM® - - - 9–25
(EXTEM-MCF)-(FIBTEM®-MCF) - - - 41–48
Multiplate® AUC (U) Aggr (AU) Vel (AU/min)
ADPtest 57–113 108–122 16–19
COLtest 72–125 126–140 18–21
TRAPtest 84–128 140–152 24–26
CT: Clotting time. s: seconds. CFT: Clot formation time. MCF: Maximum clot firmness. AUC: Area under curve. Aggr: aggregation. Vel: velocity. U: units. AU: area
units. min: minute.
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done. He received a combined general inhalational and
epidural anesthetic and received 1000mL hydroxyethyl
starch (Venofundin® 60mg/mL) during the operation.
Blood loss during the operation was 300mL. It was
considered clinically appropriate to remove his epidural
catheter on the third postoperative day and coagulation
tests were drawn from his heparinized Port-a-Cath™
(which has an internal volume of 1.3mL): the first 10mL
blood was discarded. His aPTT was prolonged to 50
seconds and his Plc of 149 was slightly lower than
expected.
ROTEM® results were all within the normal limits but
there was a discrepancy between INTEM, a measure of
the intrinsic pathway, and HEPTEM® which is identical
other than it contains heparinase which removes any
effect of heparin: clotting time (CT) was 100 seconds
shorter for HEPTEM® than INTEM (154 seconds com-
pared to 261 seconds). Multiplate® results were around
the lower limits of the reference range (ADP-AUC was
60U). Routine tests the next day (see Table 4) sampled
from a peripheral vein, were normalized despite the
patient having received the same dose of low-molecular-
weight heparin as on the previous days. The ROTEM®
results show that the first sample taken was contami-
nated by heparin despite 10mL of dead space being
withdrawn from the Port-a-Cath™ system which had an
internal volume of 1.3mL. A repeat test could have beingTable 3 Routine laboratory results for Case report 1
Hb g/L PT
Preoperative 123 1.2
First postoperative day 103 2.5
At time of epidural catheter removal, fourth postoperative day. 107 1.5
APTT: activated partial thromboplastin time. Hb: hemoglobin. Plc: platelet count. PT
reference range.run on the same day, allowing earlier removal of this
epidural catheter.
Case report 3: normal ROTEM® and Multiplate® results
despite an activated partial thromboplastin time of 47
seconds and borderline prothrombin time-international
normalized ratio at time of epidural removal
A previously healthy 52-year-old woman weighing 65kg
received a combined general inhalational and epidural
anesthetic for Whipple’s procedure due to pancreas
cancer. Perioperative hemorrhage was 200mL and she
received 1500mL hydroxyethyl starch (Venofundin®
60mg/mL) in addition to crystalloid infusions. She re-
ceived standard thrombosis prophylaxis postoperatively.
Her epidural catheter unfortunately failed to give effect-
ive analgesia and the decision to remove the catheter
was made on the second postoperative day. Routine
coagulation tests showed that PT-INR had increased to
1.2 and aPTT was slightly elevated to 47 seconds (see
Table 5). ROTEM® and Multiplate® results were all
normal: EXTEM-MCF was 70mm and Multiplate®-AUC
was 90U. Her epidural catheter was removed without
complication. As many clinicians would have delayed
manipulation of this patient’s epidural given the slightly
elevated aPTT and PT-INR at the upper end of normal,
the ROTEM® and Multiplate® results might have con-
tributed to the decision to withdraw the catheter
without delay.-INR APTT seconds Plc 106/mL Creatinine umol/L Albumin g/L
33 266 51 38
* 44 152 43 28
* 33 179 44 29
-INR: prothrombin time-international normalized ratio. *: outside normal
Table 4 Routine laboratory results for Case report 2
Hb g/L PT-INR APTT seconds Plc 106/mL Creatinine umol/L Albumin g/L
Preoperative 142 1.0 25 230 49 36
On tenth postoperative day 107 1.0 50* 149 44 Not measured
At time of epidural catheter removal, 11th postoperative day. 113 1.0 31 178 45 Not measured
Summary of Case report 2’s routine laboratory studies. APTT: activated partial thromboplastin time. Hb: hemoglobin. Plc: platelet count. PT-INR: prothrombin
time-international normalized ratio. *: outside normal reference range.
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activated partial thromboplastin time of 47 seconds at time
of removal of epidural catheter
A previously healthy 49-year-old man weighing 93kg
who had been a cigarette smoker for 30 years, and who
took only omeprazole for chronic gastric regurgitation,
presented with a 6-week history of weight loss and
dysphagia which was diagnosed as a lower esophageal
adenocarcinoma. He received a combined general inha-
lational and epidural anesthetic for esophageal resection
and para-aortic lymph node dissection by laparotomy
and thoracotomy: a total perioperative hemorrhage of
500mL was recorded and in addition to crystalloid infu-
sions, this patient received 1500mL of hydroxyethyl starch
(Venofundin® 60mg/mL) and 250mL of 5% human albu-
min. His postoperative recovery was uncomplicated and
routine coagulation tests on postoperative day 8 were
normal, although it may be noted that this patient’s blood
albumin and hemoglobin were low (25g/L and 96g/L
respectively). (See Table 6). Tests on postoperative day 10
showed a slightly elevated aPTT of 47 seconds, a throm-
bocytosis and Multiplate® results indicated strong platelet
aggregation: the ADP test showed an AUC of 144U, AGG
(aggregation) 244AU and VEL (velocity) 39.7AU/minute
(see Table 2 for reference ranges). ROTEM® results were
within the reference intervals and the epidural catheter
was removed without complication. Again, ROTEM® and
Multiplate® might have contributed to the decision to re-
move the epidural catheter despite an aPTT suggesting
mild coagulopathy.
Discussion
This pilot study constitutes a small collection of some-
what heterogeneous data but does bring to light several
important topics concerning ‘coagulative safety’ in the
context of postoperative epidural anesthesia. There may
be a place for these tests in routine practice, although
this is currently not realistic due to these tests’ lack of
validation in this setting, their operator-dependency andTable 5 Routine laboratory results for Case report 3
Hb g/L PT-I
Preoperative 130 1.0
At time of epidural catheter removal, 2nd postoperative day. 123 1.2
Summary of Case report 3’s routine laboratory studies. APTT: activated partial throm
time-international normalized ratio. *: outside normal reference range.the fact that few hospital laboratories offer these tests
for routine clinical use.
There appears to be a lack of concordance between
whole blood viscoelastic tests and routine coagulation
tests in the postoperative context, which brings current
guidelines and the usefulness of both types of test in to
question.
While PT-INR and aPTT would appear to indicate a
trend towards postoperative coagulopathy in this and
other studies [7], ROTEM® and Multiplate® suggested a
trend towards postoperative hypercoagulation in this
study.
Davignon et al. emphasize the importance of monitor-
ing coagulation before removal of epidural catheters in
case manipulation should disturb a clot and initiate an
epidural hematoma, which they describe in a patient
who received anticoagulation shortly after removal of an
epidural catheter [8].
Current guidelines do not clearly describe what to do
when there is a clinically pressing indication for remov-
ing an epidural catheter amidst laboratory tests indicat-
ing a coagulopathy: delaying removal of the epidural
catheter in Case report 1 (in which PT-INR was 1.5)
might possibly have delayed mobilization but there was
no suspicion of local infection or sepsis, which would
have made delayed withdrawal of the catheter potentially
dangerous. The American Society of Regional Anesthesia
and Pain Medicine recommends a PT-INR of 1.4 or
lower but does not mention aPTT or Plc. That guide-
lines do not address aPTT is unfortunate since over half
of the cases of spinal hematoma described by Miyazaki
et al. were treated with anticoagulant therapy which
would not necessarily be detected by the PT-INR alone
[2]. Should anticoagulation be reversed, and if so how?
PT-INR is best validated for monitoring the effect of
vitamin K antagonists such as warfarin, which was not
something that we give patients undergoing major
surgery. Viscoelastic tests are insensitive to increases
in PT-INR: ROTEM®-CT is prolonged first when theNR APTT seconds Plc 106/mL Creatinine umol/L Albumin g/L
32 201 60 Not measured
47* 146 54 Not measured
boplastin time. Hb: hemoglobin. Plc: platelet count. PT-INR: prothrombin
Table 6 Routine laboratory results for Case report 4
Hb g/L PT-INR APTT seconds Plc 106/mL Creatinine umol/L Albumin g/L
Preoperative 148 Not measured 293 61 40
At time of epidural catheter removal, tenth postoperative day. 96 1.0 47* 524 71 25
Summary of Case report 4’s routine laboratory studies. APTT: activated partial thromboplastin time. Hb: hemoglobin. Plc: platelet count. PT-INR: prothrombin
time-international normalized ratio. *: outside normal reference range.
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neither TEG® nor ROTEM® are validated for reversal
of vitamin K antagonism with prothrombin complex
concentrate. Tissue factor can be used as an activator to
give viscoelastic tests better sensitivity for PT, but this is at
present not commercially available [9]. ROTEM® and
Multiplate® nevertheless gave the clinician looking after
the patient in Case report 1 the confidence to remove her
epidural catheter [10].
There is a report by Hepner et al., of TEG®, technically
similar to ROTEM®, being used to monitor coagulation
at the time of removal of epidural catheters in 52 ortho-
pedic patients treated with low-dose warfarin to give a
PT-INR of up to 1.5 [11]. This is an attractive concept
since the risk of spinal hematoma after epidural cathe-
terization may be highest after such procedures and a
point-of-care test might allow for more accurate
prescription of warfarin [1]. TEG® was insensitive to
warfarin’s effects in Hepner and colleague’s study which,
like all studies in this area, was underpowered to draw any
conclusion about TEG® and PT-INR’s predictive value re-
garding the risk of spinal hematoma. There are several
commercial point-of-care whole-blood PT assays available:
Hemochron Junior®, iStat® and Coaguchek Pro®.
There is no conclusive evidence that it is unsafe to
place an epidural catheter when the Plc is less than
100×106/mL, yet this is the generally accepted recom-
mendation [4,12]. None of our patients had thrombo-
cytopenia and it was of no surprise that both the number
of platelets and Multiplate®-ADP-AUC increased with
time after operation as part of the general postoperative
inflammatory reaction. Being able to trust measures of
platelet function in thrombocytopenic patients would
be desirable, and being able to monitor the effect of
attempted amelioration of platelet function with des-
mopressin for example, would be attractive since it
might avoid unnecessary platelet transfusion.
Figure 1 shows three measures which correlate
positively to length of time after operation, presumably
as part of the inflammatory reaction. They are Plc,
ROTEM®-EXTEM-MCF and Multiplate®-ADP-AUC. The
difference between the MCF of ROTEM®-EXTEM and
ROTEM®-FIBTEM® becomes smaller since the extrinsic
pathway does not increase in activity as a whole despite
hyperfibrinogenemia. ROTEM®-(EXTEM-FIBTEM®) would
therefore not appear to be a useful measure of plateletfunction in the context of dynamic postoperative inflam-
mation [13].
Meticulous sampling technique is paramount
Case report 2 demonstrates that preanalytical errors
such as contamination with heparin can remove any
potential benefit that a test might offer. An experienced
clinician, however, ought to notice a difference in CT of
100 seconds between HEPTEM® and INTEM, consider
sampling technique and ask for a repeat blood sample
taken by venepuncture or from a non-heparinized line.
Since results from ROTEM® are available in real time, it
should be possible to obtain these even before initial
routine coagulation results are obtained from the
hospital laboratory. ROTEM®-HEPTEM® and INTEM
were certainly useful in this patient, who had several
factors that predisposed to coagulation defects: malnu-
trition, multiple medications, a large infusion of hydro-
xyethyl starch, major operative trauma and slightly low
Plc. It is noteworthy that viscoelastic tests are not
capable of monitoring thromboprophylactic dosages of
low-molecular-weight heparin [14].
It is significant that 18 of the 480 ROTEM® results
(4%) were excluded due to artifacts or suspicion that the
wrong reagents had been used. Point-of-care tests have
the limitation that they are often used by clinicians who
are competent to interpret the results but who are
neither trained to use nor experienced in using the
equipment. Running ROTEM® and Multiplate®, for ex-
ample, involves pipetting several different reagents. The
operator has ample opportunity to use the wrong or
contaminated materials, or even the wrong blood
sample. Some of these sources of error are eliminated by
those hospital laboratories which have introduced ‘point-
of-care’ tests with telemetry: samples are sent to the
laboratory and run by trained and experienced techni-
cians. Results are displayed in real time on a monitor at
the Intensive Care Unit or operating theatres.
Possible iatrogenic coagulopathy
It is troubling that patients 1, 3 and 4 had routine
laboratory results suggesting a coagulopathy without our
knowing for certain why. Lack of diagnosis precludes
specific prevention and treatment. Patient 1’s spon-
taneously transient but somewhat dramatic increase in
PT-INR from 1.2 to 2.5 has several possible explanations:
Thomas et al. Journal of Medical Case Reports 2013, 7:282 Page 9 of 10
http://www.jmedicalcasereports.com/content/7/1/282dilutional coagulopathy and platelet inhibition by infusion
of 2L of synthetic colloid and 250mL albumin; loss of
coagulation factors by hemorrhage and possibly inability
to synthetize new factors due to preoperative malnutrition
and systemic inflammation [15]. It is also possible that our
current practice of prescribing 40mg of enoxaparin as
thrombosis prophylaxis to all patients regardless of weight
leads to accumulation and coagulopathy in smaller
patients who have decreased renal function. It is clearly
of interest to prospectively and directly investigate
coagulation factors and indicators of malnutrition in
the perioperative period. We are currently running a
study of this type.
The importance of being sensible
Since there is no optimal or validated method to predict
the risk of epidural hematoma one must be vigilant for
signs and symptoms of epidural hematoma not only
after catheterization but also after removing an epidural
catheter. Magnetic resonance imaging should be carried
out early to enable surgical intervention to avoid neuro-
logical damage.
So long as we are not sure why a patient’s coagulation
tests indicate coagulopathy before removal of an epiduralTable 7 Overview of ROTEM® parameters
Trade name Content Act
1 NATEM
(= ‘classic thromboelastometry’)
Only recalcification agent. Non
con
mea
2 EXTEM Tissue factor and phospholipids. Acti
3 INTEM Ellagic acid and
phospholipids.
Acti
4 FIBTEM® As EXTEM, plus
cytochalasin D.
Cyto
5 APTEM As EXTEM, plus aprotinin. Apr
ther
6 HEPTEM® As INTEM, plus heparinase I. Deg
CT (Clotting time) Gives information about the kinetics o
clot development. Prolongation of CT
heparin or coagulation factor deficienc
CFT (Clotting formation time) Gives information about the rate of clo
as the interval between the onset of c
as when the amplitude is 2mm, and th
of 20mm. A prolonged CFT but norma
polymerization disorder.
AA (Alpha angle) Indicates the rate at which a solid clot
angle are influenced by coagulation fa
function and fXIII.
MCF (Maximum clot firmness) Shows the maximal strength and stabi
clot. A reduced MCF and normal CFT s
and/or platelets.
Contents according to manufacturer’s information (Pentapharm, Munich, Germany).catheter, we cannot be sure how to treat them. Current
strategies at our hospital include administration of be-
tween 10 and 30mg vitamin K per day and stopping
enoxaparin, then taking new coagulation tests a day
later. Transfusions of plasma have previously been
given before the removal of catheters without further
testing.
Conclusions
This pilot study is new in that it examines ROTEM® and
Multiplate® at the time of epidural catheter removal.
These point-of-care tests may have a role to play in this
setting since they showed a normal or hypercoagulative
signal in most patients despite aPTT and PT-INR show-
ing a trend towards the hypocoagulable.
Normal values need to be defined for viscoelastic tests
and platelet aggregometry after major surgery. ROTEM®-
(EXTEM minus FIBTEM®)-MCF does not appear to be a
suitable measurement of platelet function.
At present we do not know enough about the
pathophysiology of postoperative coagulation defects:
the causes of prolonged PT-INR and aPTT should be
investigated further, including the effects of synthetic
starches.ion Relevance
e – coagulation is activated by
tact with the surface of the
surement container.
Produces a curve representing ‘
whole blood coagulation’.
vates the extrinsic pathway. CT corresponds to PT. Curve represents
clot formation, stability and fibrinolysis
resulting from the extrinsic pathway.
vates the intrinsic pathway. CT corresponds to aPTT.
chalasin D inhibits platelets. Allows qualitative assessment of
fibrinogen levels.
otinin inhibits plasmin and
efore fibrinolysis.
Comparing EXTEM and APTEM can rule
in or out hyperfibrinolysis.
rades heparin. A comparison of HEPTEM® and INTEM
indicates how much coagulation is
affected by heparin.
f fibrin formation and
may be a result of
y.
t formation. It is calculated
oagulation, arbitrarily defined
e curve reaching an amplitude
l MCF indicates a clot
forms. Both CFT and alpha
ctors, platelet count and/or
lity of the fibrin and platelet
uggest lack of fibrinogen
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On the day on which patients’ epidural catheters were to
be removed, venous blood was sampled from indwelling
peripheral or central venous catheters, which is routine
practice at our hospital. ROTEM® and Multiplate® were
run on this blood at the same time as the standard
coagulation tests described in Table 1. Routine test re-
sults, both pre- and postoperative, were retrieved from
the hospital’s electronic notes system (Melior, Siemens
Healthcare, Upplands Väsby, Sweden).
ROTEM®
Thromboelastometry was carried out using the ROTEM®
(rotational thromboelastometry) apparatus (Pentapharm,
Munich, Germany) according to the manufacturer’s
instructions. ROTEM® assays were run for 60 minutes.
Each sample was analyzed by ROTEM® using each of
the six activators described in Table 7. Recalcification
was carried out using 20μL of 0.2M calcium chloride
(Star-TEM™). The following variables were registered:
CT, CFT, alpha-angle (AA), and MCF.
Multiplate®
Impedance aggregometry was carried out using the
Multiplate® analyzer (Roche, Basel, Switzerland) accord-
ing to the manufacturer’s instructions. Three platelet
receptor agonists were applied: ADPtest, COLtest and
TRAPtest, which activate coagulation with ADP, COL
and thrombin receptor activating peptide 6 respectively.
The following results were recorded for each agonist in
each patient: area under curve, aggregation, and velocity.
Normal values are described in Table 2.
Data was initially recorded on paper case report forms
and later entered into an Excel sheet before statistical
analysis using the statistical computing environment ‘R’
[16]. The significance of differences between pre- and
postoperative test results were tested with Student’s
paired t-test. Pearson’s product moment correlation test
was used to define correlation coefficients.
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Written informed consent was obtained from all 20 pa-
tients involved in this study for publication of this case
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